Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kränzlin B[au]:

Upregulation of Tumor Susceptibility Gene 101 (TSG101) by mechanical stress in podocytes. Sunohara M et al. Cell Mol Biol (Noisy-le-grand). (2019)

Renal phenotype of young and old telomerase-deficient mice. Schildhorn C et al. Mech Ageing Dev. (2015)

CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD). Gauer S et al. J Histochem Cytochem. (2017)

Search results

Items: 1 to 50 of 57

1.

Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal model.

Gomarteli K, Fleckenstein J, Kirschner S, Bobu V, Brockmann MA, Henzler T, Meyer M, Riffel P, Schönberg SO, Veldwijk MR, Kränzlin B, Hoerner C, Glatting G, Wenz F, Herskind C, Giordano FA.

Sci Rep. 2019 Oct 29;9(1):15489. doi: 10.1038/s41598-019-51735-3.

2.

Upregulation of Tumor Susceptibility Gene 101 (TSG101) by mechanical stress in podocytes.

Sunohara M, Kriz W, Kränzlin B, Kretzler M, Gretz N, Endlich K, Endlich N.

Cell Mol Biol (Noisy-le-grand). 2019 Jan 31;65(1):84-88.

PMID:
30782301
3.

CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD).

Gauer S, Holzmann Y, Kränzlin B, Hoffmann SC, Gretz N, Hauser IA, Goppelt-Struebe M, Geiger H, Obermüller N.

J Histochem Cytochem. 2017 Dec;65(12):743-755. doi: 10.1369/0022155417735513. Epub 2017 Oct 23.

4.

Fluorescently Labeled Cyclodextrin Derivatives as Exogenous Markers for Real-Time Transcutaneous Measurement of Renal Function.

Huang J, Weinfurter S, Pinto PC, Pretze M, Kränzlin B, Pill J, Federica R, Perciaccante R, Ciana LD, Masereeuw R, Gretz N.

Bioconjug Chem. 2016 Oct 19;27(10):2513-2526. Epub 2016 Sep 22.

PMID:
27611623
5.

Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease.

Gauer S, Urbschat A, Gretz N, Hoffmann SC, Kränzlin B, Geiger H, Obermüller N.

Int J Mol Sci. 2016 May 24;17(6). pii: E802. doi: 10.3390/ijms17060802.

6.

Renal phenotype of young and old telomerase-deficient mice.

Schildhorn C, Jacobi C, Weissbrodt A, Hermstedt C, Westhoff JH, Hömme M, Bhayadia R, Gretz N, Falk CS, Schmitt R, Bröcker V, Kränzlin B, Melk A.

Mech Ageing Dev. 2015 Sep;150:65-73. doi: 10.1016/j.mad.2015.08.004. Epub 2015 Aug 12.

PMID:
26277387
7.

Nephrotoxicity of ibandronate and zoledronate in Wistar rats with normal renal function and after unilateral nephrectomy.

Bergner R, Siegrist B, Gretz N, Pohlmeyer-Esch G, Kränzlin B.

Pharmacol Res. 2015 Sep;99:16-22. doi: 10.1016/j.phrs.2015.04.016. Epub 2015 May 11.

PMID:
25976681
8.

Rapid identification of goblet cells in unstained colon thin sections by means of quantum cascade laser-based infrared microspectroscopy.

Kröger-Lui N, Gretz N, Haase K, Kränzlin B, Neudecker S, Pucci A, Regenscheit A, Schönhals A, Petrich W.

Analyst. 2015 Apr 7;140(7):2086-92. doi: 10.1039/c4an02001d.

PMID:
25649324
9.

Quantum cascade laser-based hyperspectral imaging of biological tissue.

Kröger N, Egl A, Engel M, Gretz N, Haase K, Herpich I, Kränzlin B, Neudecker S, Pucci A, Schönhals A, Vogt J, Petrich W.

J Biomed Opt. 2014;19(11):111607. doi: 10.1117/1.JBO.19.11.111607.

10.

Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.

Boehn SN, Spahn S, Neudecker S, Keppler A, Bihoreau MT, Kränzlin B, Pandey P, Hoffmann SC, Li L, Torres VE, Gröne HJ, Gretz N.

Nephrol Dial Transplant. 2013 Aug;28(8):2045-58. doi: 10.1093/ndt/gft014. Epub 2013 Mar 29.

11.

Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors.

Kiss E, Kränzlin B, Wagenblaβ K, Bonrouhi M, Thiery J, Gröne E, Nordström V, Teupser D, Gretz N, Malle E, Gröne HJ.

Am J Pathol. 2013 Mar;182(3):727-41. doi: 10.1016/j.ajpath.2012.11.033. Epub 2013 Jan 12.

PMID:
23318573
12.

Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function.

Bergner R, Siegrist B, Kränzlin B, Gretz N, Faust H, Pfister T.

J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):225-230. doi: 10.1016/j.vascn.2012.12.001. Epub 2012 Dec 20.

PMID:
23261819
13.

New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.

Gabriel U, Li L, Bolenz C, Steidler A, Kränzlin B, Saile M, Gretz N, Trojan L, Michel MS.

Mol Carcinog. 2012 Nov;51(11):907-15. doi: 10.1002/mc.20860. Epub 2011 Oct 4.

PMID:
21976419
14.

Validation of a new non-invasive blood pressure measurement method on mice via pulse wave propagation time measurement on a cuff.

Nguyen XP, Kronemayer R, Herrmann P, Mejía A, Daw Z, Nguyen XD, Kränzlin B, Gretz N.

Biomed Tech (Berl). 2011 Jun;56(3):153-8. doi: 10.1515/BMT.2011.013.

PMID:
21657988
15.

Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats.

Neudecker S, Walz R, Menon K, Maier E, Bihoreau MT, Obermüller N, Kränzlin B, Gretz N, Hoffmann SC.

Am J Pathol. 2010 Dec;177(6):3000-9. doi: 10.2353/ajpath.2010.100569.

16.

Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways.

Koupepidou P, Felekkis KN, Kränzlin B, Sticht C, Gretz N, Deltas C.

BMC Nephrol. 2010 Sep 2;11:23. doi: 10.1186/1471-2369-11-23. Erratum in: BMC Nephrol. 2011;12:6.

17.

Telomere shortening reduces regenerative capacity after acute kidney injury.

Westhoff JH, Schildhorn C, Jacobi C, Hömme M, Hartner A, Braun H, Kryzer C, Wang C, von Zglinicki T, Kränzlin B, Gretz N, Melk A.

J Am Soc Nephrol. 2010 Feb;21(2):327-36. doi: 10.1681/ASN.2009010072. Epub 2009 Dec 3.

18.

Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia.

Bergmann C, Fliegauf M, Brüchle NO, Frank V, Olbrich H, Kirschner J, Schermer B, Schmedding I, Kispert A, Kränzlin B, Nürnberg G, Becker C, Grimm T, Girschick G, Lynch SA, Kelehan P, Senderek J, Neuhaus TJ, Stallmach T, Zentgraf H, Nürnberg P, Gretz N, Lo C, Lienkamp S, Schäfer T, Walz G, Benzing T, Zerres K, Omran H.

Am J Hum Genet. 2008 Apr;82(4):959-70. doi: 10.1016/j.ajhg.2008.02.017. Epub 2008 Mar 27.

19.

Diethylhexylphthalate extracted by typical newborn lipid emulsions from polyvinylchloride infusion systems causes significant changes in histology of rabbit liver.

Loff PD, Subotic U, Oulmi-Kagermann J, Kränzlin B, Reinecke MF, Staude C.

JPEN J Parenter Enteral Nutr. 2007 May-Jun;31(3):188-93.

PMID:
17463143
20.

StAR expression and the long-term aldosterone response to high-potassium diet in Wistar-Kyoto and spontaneously hypertensive rats.

Peters B, Teubner P, Clausmeyer S, Puschner T, Maser-Gluth C, Wrede HJ, Kränzlin B, Peters J.

Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E16-23. Epub 2006 Aug 1.

21.

Distinct immunohistochemical expression of osteopontin in the adult rat major salivary glands.

Obermüller N, Gassler N, Gretz N, Kränzlin B, Hoffmann S, Geiger H, Gauer S.

J Mol Histol. 2006 Jan;37(1-2):53-60. Epub 2006 Jul 3.

PMID:
16817053
22.

Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements.

Pill J, Issaeva O, Woderer S, Sadick M, Kränzlin B, Fiedler F, Klötzer HM, Krämer U, Gretz N.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Jun;373(3):204-11. Epub 2006 May 12.

PMID:
16736157
23.

Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition.

Torremans A, Marescau B, Kränzlin B, Gretz N, Billiouw JM, Vanholder R, De Smet R, Bouwman K, Brouns R, De Deyn PP.

Kidney Int. 2006 Jun;69(11):2003-12.

24.

Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rats with renal insufficiency.

Tillmann HC, Kuhn B, Kränzlin B, Sadick M, Gross J, Gretz N, Pill J.

Kidney Int. 2006 Jan;69(1):60-7.

25.

Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.

Brown JH, Bihoreau MT, Hoffmann S, Kränzlin B, Tychinskaya I, Obermüller N, Podlich D, Boehn SN, Kaisaki PJ, Megel N, Danoy P, Copley RR, Broxholme J, Witzgall R, Lathrop M, Gretz N, Gauguier D.

J Am Soc Nephrol. 2005 Dec;16(12):3517-26. Epub 2005 Oct 5.

26.

Biocompatibility of an electrochemical sensor for continuous glucose monitoring in subcutaneous tissue.

Mang A, Pill J, Gretz N, Kränzlin B, Buck H, Schoemaker M, Petrich W.

Diabetes Technol Ther. 2005 Feb;7(1):163-73.

PMID:
15738714
27.

Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis.

Kriz W, Hähnel B, Hosser H, Ostendorf T, Gaertner S, Kränzlin B, Gretz N, Shimizu F, Floege J.

J Am Soc Nephrol. 2003 Jul;14(7):1904-26.

28.

Expression of calnexin reflects paneth cell differentiation and function.

Gassler N, Schnölzer M, Rohr C, Helmke B, Kartenbeck J, Grünewald S, Laage R, Schneider A, Kränzlin B, Bach A, Otto HF, Autschbach F.

Lab Invest. 2002 Dec;82(12):1647-59.

29.

Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries.

Hidaka S, Kränzlin B, Gretz N, Witzgall R.

Cell Tissue Res. 2002 Dec;310(3):289-96. Epub 2002 Oct 2.

PMID:
12457227
30.

Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress.

Endlich N, Sunohara M, Nietfeld W, Wolski EW, Schiwek D, Kränzlin B, Gretz N, Kriz W, Eickhoff H, Endlich K.

FASEB J. 2002 Nov;16(13):1850-2. Epub 2002 Sep 19.

PMID:
12354696
31.

Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy/+) rat in a region conserved with a mouse modifier locus for Alport syndrome.

Bihoreau MT, Megel N, Brown JH, Kränzlin B, Crombez L, Tychinskaya Y, Broxholme J, Kratz S, Bergmann V, Hoffman S, Gauguier D, Gretz N.

Hum Mol Genet. 2002 Sep 1;11(18):2165-73.

PMID:
12189169
32.

Altered expression pattern of polycystin-2 in acute and chronic renal tubular diseases.

Obermüller N, Cai Y, Kränzlin B, Thomson RB, Gretz N, Kriz W, Somlo S, Witzgall R.

J Am Soc Nephrol. 2002 Jul;13(7):1855-64.

33.

Impaired endocytosis may represent an obstacle to gene therapy in polycystic kidney disease.

Witzgall R, Kränzlin B, Gretz N, Obermüller N.

Kidney Int. 2002 Jan;61(1 Suppl):S132-7.

34.

Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat.

Gassler N, Elger M, Kränzlin B, Kriz W, Gretz N, Hähnel B, Hosser H, Hartmann I.

Kidney Int. 2001 Jul;60(1):106-16.

35.

Changes of AT(2) receptor levels in the rat adrenal cortex and medulla induced by bilateral nephrectomy and its modulation by circulating ANG II.

Peters B, Clausmeyer S, Teubner P, Obermüller N, Kränzlin B, Gretz N, Inagami T, Peters J.

J Histochem Cytochem. 2001 May;49(5):649-56.

PMID:
11304803
36.

An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease.

Obermüller N, Kränzlin B, Blum WF, Gretz N, Witzgall R.

Am J Physiol Renal Physiol. 2001 Feb;280(2):F244-53.

37.

Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis.

Kriz W, Hartmann I, Hosser H, Hähnel B, Kränzlin B, Provoost A, Gretz N.

J Am Soc Nephrol. 2001 Mar;12(3):496-506.

38.

A possible role for metalloproteinases in renal cyst development.

Obermüller N, Morente N, Kränzlin B, Gretz N, Witzgall R.

Am J Physiol Renal Physiol. 2001 Mar;280(3):F540-50.

39.

Altered expression of type II sodium/phosphate cotransporter in polycystic kidney disease.

Vogel M, Kränzlin B, Biber J, Murer H, Gretz N, Bachmann S.

J Am Soc Nephrol. 2000 Oct;11(10):1926-32.

40.

Cardiovascular risk, renal hypertensive damage, and effects of amlodipine treatment in transgenic TGR(mREN2)27 rats.

Witte K, Schnecko A, Schmidt T, Voll C, Kränzlin B, Lemmer B.

Gen Pharmacol. 1999 Nov;33(5):423-30.

PMID:
10553884
41.

Parenteral nutrition-induced hepatobiliary dysfunction in infants and prepubertal rabbits.

Loff S, Kränzlin B, Moghadam M, Dzakovic A, Wessel L, Back W, Hosie S, Wirth H, Waag KL.

Pediatr Surg Int. 1999;15(7):479-82.

PMID:
10525903
42.

How does podocyte damage result in tubular damage?

Kriz W, Elger M, Hosser H, Hähnel B, Provoost A, Kränzlin B, Gretz N.

Kidney Blood Press Res. 1999;22(1-2):26-36. Review.

43.

Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system.

Peters J, Obermüller N, Woyth A, Peters B, Maser-Gluth C, Kränzlin B, Gretz N.

Endocrinology. 1999 Feb;140(2):675-82.

PMID:
9927293
44.

Specific regulation of StAR expression in the rat adrenal zona glomerulosa. An in situ hybridization study.

Peters B, Clausmeyer S, Obermüller N, Woyth A, Kränzlin B, Gretz N, Peters J.

J Histochem Cytochem. 1998 Nov;46(11):1215-21.

PMID:
9774620
45.

Long-term total parenteral nutrition-induced hepatobiliary dysfunction in a rabbit model.

Loff S, Waag KL, Kränzlin B, Zovko D, Dzakovic A, Jester I, Wirth H, Wessel L.

J Pediatr Surg. 1998 May;33(5):694-9.

PMID:
9607470
46.

Acute effects of bezafibrate on blood pressure and renal haemodynamics in SHR and WKY rats.

Agrawal B, Kopecký J, Kränzlin B, Rohmeiss P, Pill J, Gretz N.

Nephrol Dial Transplant. 1998 Feb;13(2):333-9.

PMID:
9509443
47.

Extracorporeal therapies in acute renal failure: different therapeutic options.

Gretz N, Quintel M, Kränzlin B.

Kidney Int Suppl. 1998 Feb;64:S57-60. Review. No abstract available.

PMID:
9475491
48.

Renal osmotic stress-induced cotransporter: expression in the newborn, adult and post-ischemic rat kidney.

Obermüller N, Kränzlin B, Verma R, Gretz N, Kriz W, Witzgall R.

Kidney Int. 1997 Dec;52(6):1584-92.

49.

Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/+ rat.

Bihoreau MT, Ceccherini I, Browne J, Kränzlin B, Romeo G, Lathrop GM, James MR, Gretz N.

Hum Mol Genet. 1997 Apr;6(4):609-13.

PMID:
9097967
50.

Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.

Kränzlin B, Schieren G, Gretz N.

Kidney Int. 1997 Apr;51(4):1160-9.

Supplemental Content

Loading ...
Support Center